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Analytically useful blue chemiluminescence
from a water-soluble iridium(III) complex
containing a tetraethylene glycol functionalised
triazolylpyridine ligand†
Zoe M. Smith,a Emily Kerr,a Egan H. Doeven,b Timothy U. Connell,a,c
Neil W. Barnett,a Paul S. Donnelly,c Stephen J. Haswellb and Paul S. Francis*a
We examine [Ir(df-ppy)2(pt-TEG)]
+ as the ﬁrst highly water soluble,
blue-luminescent iridium(III) complex for chemiluminescence
detection. Marked diﬀerences in selectivity were observed
between the new complex and the conventional [Ru(bpy)3]
2+
reagent, which will enable this mode of detection to be extended
to new areas of application.
Cyclometalated iridium(III) complexes exhibiting high lumine-
scence eﬃciencies and a wide range of emission colours1 are
seen as promising alternatives to the ruthenium(II) complexes
traditionally employed for photoluminescence, chemilumines-
cence and electrochemiluminescence (ECL). The use of
iridium(III) complexes oﬀers opportunities to manipulate
detection selectivity, shift the emission into the most sensitive
wavelength range of conventional photomultiplier tubes, and
develop multicolour detection systems.2,3 However, the poor
aqueous solubility of many available iridium(III) complexes has
limited their application in these areas. In cases where only
low concentrations of the luminophore are required, such as
photoluminescence protein staining, cellular imaging and
molecular probes,4,5 or ECL labelling for immunoassay,6
suﬃcient solubility has been derived by including a neutral
ligand to impart an overall positive charge to the complex, or a
derivative containing sulfonate or saccharide groups.3,4,7–9 ‡
For chemiluminescence detection systems in which the metal
complexes are used at relatively high concentrations to detect
reducing agents (such as tertiary amines),10 these approaches
have not resulted in adequate solubility and/or have restricted
emission wavelengths to regions of green to red light. Never-
theless, explorations of iridium(III) complexes as chemilumine-
scence reagents7,9,11–13 have shown diﬀerences in the
selectivity of their light producing reactions, and for some ana-
lytes, more intense emissions than those from analogous reac-
tions with conventional ruthenium(II)-based reagents.7,9,12
We previously examined a series of chemiluminescence
reactions of [Ir(C^N)2(BPS)]
− complexes9,12 (where C^N represents
the cyclometalating phenylisoquinoline (piq), phenylpyridine
(ppy), phenylbenzothiazole (bt) or difluorophenylpyridine (df-
ppy) ligands, and BPS is bathophenanthroline disulfonate),
which exhibited red, orange, yellow and green emissions,
respectively. The BPS ligand imparted significant solubility in
aqueous solution, but a 1 : 1 mixture of water : acetonitrile was
required to prepare the reagents at 1 mM.9,12 Using a flow-
injection analysis manifold, the reagents were oxidised with
cerium(IV) sulfate before reacting with a variety of analytes.
Greater chemiluminescence intensities were generally obtained
using [Ir(df-ppy)2(BPS)]
− or [Ir(bt)2(BPS)]
− than with [Ru(bpy)3]
2+,
but the blank responses from the reaction between oxidised
iridium complexes and solvent were also greater, which reduced
the anticipated improvements in the signal-to-blank ratios.9,12
The inclusion of the BPS ligand in these complexes also induced
a bathochromic shift in the emission when compared to their
homoleptic counterparts, restricting the highest energy emission,
exhibited by [Ir(df-ppy)2(BPS)]
− (Fig. 1b), to the green region of
the spectrum (λmax = 549 nm; Fig. S1 in ESI†),
9 whereas the
corresponding neutral [Ir(df-ppy)3] complex (Fig. 1a), which is
not soluble in water, emits blue light (λmax = 495 nm).
15
In a previous attempt to create a water-soluble iridium(III)
complex exhibiting blue chemiluminescence,9 we synthesised
a sulfonated derivative of 1-phenyl-1,2,3-triazol-4-ylpyridine
(STP) as an alternative ancillary ligand to BPS. Although blue
chemiluminescence was observed from [Ir(df-ppy)2(STP)]
(Fig. 1c and S1†) upon reaction with cerium(IV) sulfate and
pharmaceuticals such as codeine, furosemide and ofloxacin,
†Electronic supplementary information (ESI) available: Chemical structure of
[Ir(ppy-SO3)2(pt-TEG)]
−, photograph of the luminescence, structure of compounds
selected for the comparison, additional relative chemiluminescence responses,
additional spectroscopic data, and calibration graphs. See DOI: 10.1039/
c6an00141f
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the aqueous solubility of the complex was poor (limited to
∼10−5 M) and its chemiluminescence intensities (and signal/
blank ratios) were generally very low compared to those of
[Ru(bpy)3]
2+ and the [Ir(C^N)2(BPS)]
− complexes. However, a
close analogue of [Ir(df-ppy)2(STP)] bearing a polyethylene
glycol substituent ([Ir(df-ppy)2(pt-TEG)]
+; Fig. 1d) was recently
identified as a promising candidate for ECL detection,16 with
high aqueous solubility and co-reactant ECL signals with tri-n-
propylamine that were over twelve times greater than those of
[Ru(bpy)3)]
2+ when measured with a typical bialkali photo-
multiplier tube. Herein, we report our investigation of [Ir(df-
ppy)2(pt-TEG)]
+ as the first highly water-soluble iridium(III)
complex exhibiting blue chemiluminescence.
We compared the chemiluminescence responses of [Ir(df-
ppy)2(pt-TEG)]
+ with that of [Ru(bpy)3]
2+ and a related
iridium(III) complex that exhibits green luminescence ([Ir(ppy-
SO3)2(pt-TEG)]
−, Fig. 2a, S2 and S3†),§ using flow injection
analysis methodology,¶ and reagent concentrations of 1 mM,
0.1 mM and 0.01 mM (Fig. 3), representing the wide range
adopted in previous analytical applications.10 The compounds
selected for the comparison: codeine, furosemide,
1-(4-trifluoromethylphenyl)piperazine, 1-(4-trifluoromethyl-
phenyl)piperidin-4-ol and ofloxacin (Fig. S4†), have previously
been shown to elicit light upon reaction with various ruthe-
nium(II) and iridium(III) complexes under acidic conditions
using cerium(IV) sulfate as an oxidant.9,18,19
Similar trends in the relative chemiluminescence intensi-
ties (and signal-to-blank ratios) were observed across the
diﬀerent reagent concentrations (Fig. 3 and S5†), but the three
reagents exhibited markedly diﬀerent selectivity. Using
[Ru(bpy)3]
2+, the greatest intensities were elicited by ofloxacin
and the piperidinol derivative, whereas using [Ir(ppy-SO3)2(pt-
TEG)]−, the piperazine derivative elicited a much greater
response than the other four compounds. Lower signals (and
S/B ratios) were observed using [Ir(df-ppy)2(pt-TEG)]
+ than
[Ru(bpy)3]
2+, with the exception of the reaction with furosemide,
which exhibited a four-fold greater S/B ratio with the blue-light
emitting iridium(III) reagent (at 1 mM and 0.1 mM metal
complex concentration).
The mechanism for the light-producing reactions of ruthe-
nium- and iridium-complexes with various amine-containing
compounds upon chemical or electrochemical oxidation
involves numerous competing reaction pathways,20,21 the most
dominant of which depends on the reaction conditions, and
the properties of not only the metal complex, but also the
amine and its radical oxidation products. The diﬀerences in
Fig. 1 Comparison of [Ir(df-ppy)2(L)]
n complexes, where L is: 2-(2,4-
diﬂuorophenyl)pyridinato (df-ppy);14,15 bathophenanthroline-disulfonate
(BPS);9,12,16 1-phenylsulfonate-1,2,3-triazol-4-ylpyridine (STP);9 or
2-triethoxyethanol[4-(2-pyridinyl)-1H-1,2,3-triazole-1-yl] (pt-TEG).16,17
Fig. 2 (a) Normalised absorption spectrum of cerium(IV) sulfate (black
line), and normalised photoluminescence emission spectra of [Ir(df-
ppy)2(pt-TEG)]
+ (blue line; λmax = 456, 483 nm), [Ir(ppy-SO3)2(pt-TEG)]
−
(green line; λmax = 482, 512 nm), and [Ru(bpy)3]
2+ (red line; λmax =
618 nm), at 10 μM in aqueous solution. (b) Normalised chemilumines-
cence spectra for 1 mM [Ir(df-ppy)2(pt-TEG)]
+ (blue line) and [Ru-
(bpy)3]
2+ (red line), with 1 mM cerium(IV) sulfate and 50 μM furosemide.
The chemiluminescence spectra were obtained under analytically rele-
vant conditions by replacing the photomultiplier tube in the ﬂow injec-
tion analysis manifold with a spectrometer with CCD detector. This
enabled measurement of the chemiluminescence spectrum for each
injection, during the time that the light-producing reaction mixture
passed through the detection ﬂow-cell. The vibrational structure in the
photoluminescence emission spectrum of [Ir(df-ppy)2(pt-TEG)]
+ was
not observed in the corresponding chemiluminescence spectrum due
to the considerably lower resolution of the CCD spectrometer
conﬁguration.
Analyst Communication
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the selectivity of the [Ru(bpy)3]
2+, [Ir(ppy-SO3)2(pt-TEG)]
− and
[Ir(df-ppy)2(pt-TEG)]
+ complexes towards these analytes can be
attributed to factors such as their oxidising strength (Eox =
1.06 V, 1.09 V and 1.43 V vs. Ag/AgCl, respectively16,20), ligand
structure and overall charge (2+, 1− and 1+, respectively),
which influence the rate of reaction leading to the emitting
species. Similar reasoning can be made for the deleterious
light-producing reaction with the solvent that produces the
‘blank’ response. The chemiluminescence intensity of the
three complexes with any particular analyte (or the solvent)
will also be limited by the luminescence quantum yield of
each complex.
The optimum reagent concentration, in terms of chemi-
luminescence S/B ratios, was found to be both analyte and
reagent dependent, in agreement with our previous investi-
gations.12 In that prior work, stopped-flow experiments indi-
cated that the changes in S/B ratio arose from the influence of
concentration on the rates of the competing reactions of
analyte and solvent with the reagent, coupled with the depen-
dence of the chemiluminescence signal measured in a flow-
injection analysis system on the reaction kinetics.12
The sensitivity of the [Ir(df-ppy)2(pt-TEG)]
+ reagent towards
furosemide compared to the other analytes under investigation
is similar under certain conditions to that observed for [Ir(df-
ppy)2(BPS)]
− (Fig. 1b),12 which also has a much higher Eox
(1.52 V vs. Ag/AgCl)16 than [Ru(bpy)3]
2+. Comparison of the
chemiluminescence intensity of [Ru(bpy)3]
2+ and [Ir(df-
ppy)2(pt-TEG)]
+ with compounds similar in structure to furose-
mide (Fig. 4 and 5) highlighted the remarkable diﬀerence in
selectivity between the two reagents. Removing the aniline
group from furosemide, or replacing its furan-2-ylmethyl sub-
stituent with a benzyl group on the anilinic nitrogen reduced
the chemiluminescence intensity with [Ir(df-ppy)2(pt-TEG)]
+ by
an order of magnitude (Fig. 6). Piretanide, which possesses a
tertiary aniline group, gave significantly greater chemi-
luminescence intensity upon reaction with [Ru(bpy)3]
2+ (and
cerium(IV)) than the other compounds, but this was not
observed for [Ir(df-ppy)2(pt-TEG)]
+.
Previously examined iridium(III) complexes often exhibited
higher chemiluminescence intensities than [Ru(bpy)3]
2+,9,12
but also showed greater blank responses from the corres-
ponding reaction with the solvent. However, this was not the
case for [Ir(df-ppy)2(pt-TEG)]
+, which gave lower blank
responses than [Ru(bpy)3]
2+. We suspected that this might be
due to partial absorption of the blue emission of [Ir(df-
ppy)2(pt-TEG)]
+ by the cerium(IV) oxidant, but the overlap of
their emission and absorption spectra is minimal
(Fig. 2a).k Consequently, there was no red-shift in the chemi-
luminescence emission compared to the photoluminescence in
the absence of cerium(IV) (Fig. 2b): visually, the light emitted
Fig. 3 Relative chemiluminescence (signal-to-blank) response for
[Ru(bpy)3]
2+, [Ir(ppy-SO3)2(pt-TEG)]
−, and [Ir(df-ppy)2(pt-TEG)]
+ at (a) 1 mM,
(b) 0.1 mM, and (c) 0.01 mM reagent concentration, with cerium(IV)
sulfate (1 mM) and various pharmaceuticals and related compounds
(1 μM), using ﬂow injection analysis methodology.
Fig. 4 Photographs of the chemiluminescence reactions of (a)
[Ru(bpy)3]
2+ and 1-(4-triﬂuoromethylphenyl)piperdin-4-ol, (b) [Ir(ppy-
SO3)2(pt-TEG)]
− and 1-(4-triﬂuoromethylphenyl)piperazine, and (c)
[Ir(df-ppy)2(pt-TEG)]
+ and furosemide, in aqueous solution. The metal
complex reagents were continuously merged with an oxidant solution
(cerium(IV) sulfate in 0.05 M H2SO4) at a T-piece shortly prior to mixing
with the other reactant solution within a transparent serpentine ﬂow-
cell.22 A Canon 6D camera with 50 mm f1.8 lens were used (Canon,
Japan). The exposure time and reactant concentrations were adjusted to
produce similar emission intensities.
Communication Analyst
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from the reaction of [Ir(df-ppy)2(pt-TEG)]
+ with cerium(IV)
sulfate and furosemide (Fig. 4) was the same blue colour as
the corresponding photoluminescence (Fig. S3†).
Calibrations for furosemide (Fig. S7†) prepared using flow
injection analysis methodology¶ with 0.1 mM [Ir(df-ppy)2(pt-
TEG)]+ (and 1 mM cerium(IV) sulfate in 0.05 mM H2SO4)
showed a superior limit of detection (1 × 10−8 M; 3σ) than that
obtained with [Ru(bpy)3]
2+ (7 × 10−8 M; 3σ) under the same
conditions. These detection limits are comparable to those
reported in previous studies based on chemiluminescence
reactions with [Ru(bpy)3]
2+ (8 × 10−9 M to 2 × 10−7 M),12,23,24
[Ru(BPS)3]
4− (1 × 10−8 M to 3 × 10−8 M),18,24 and [Ir(df-
ppy)2(BPS))]
− (1 × 10−8 M),12 where cerium(IV) was used as the
oxidant.
Conclusions
These preliminary investigations of the [Ir(df-ppy)2(pt-TEG)]
+
complex as a chemiluminescence reagent reveal a viable
approach to develop new detection systems based on chemi-
cally induced blue luminescence from metal complexes under
analytically useful aqueous conditions. The use of polyethylene
glycol groups is a more eﬀective option to enhance solubility
in water than previous attempts involving ligands with sulfo-
nate groups.9,12 The ability to shift the emission bands into
the blue region of the visible spectrum is advantageous for the
development of miniaturised analytical devices with low-cost
photodetectors. Moreover, the striking diﬀerences in the
selectivity of these novel chemiluminescence reagents com-
pared to traditional ruthenium(II) polypyridine complexes will
expand the scope of chemiluminescence detection into new
areas of application.
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Notes and references
‡Similarly, water-soluble iridium-based catalysts have been prepared incorporat-
ing a tertiary phosphine ligand with multiple sulfonate substituents.25
§ [Ir(df-ppy)2(pt-TEG)]Cl and Na[Ir(ppy-SO3)2(pt-TEG)] were prepared as pre-
viously described.16 [Ru(bpy)3]Cl2·6H2O was purchased from Strem (MA, USA).
¶Flow injection analysis was used to reproducibly combine the reactants. The
manifold was assembled as described previously,11 which included a GloCel
chemiluminescence detector (Global FIA, MA, USA) with dual-inlet serpentine
flow-cell26 and an Electron Tubes model 9125B photomultiplier tube (ETP, NSW,
Australia). The aqueous metal-complex reagent solutions were injected (70 μL)
into a carrier line containing the 1 mM cerium(IV) sulfate (in 0.05 M H2SO4),
which merged with the analyte solution within the detection flow-cell. A flow
rate of 3.5 mL min−1 per line was used in all experiments.
kAbsorption spectra were obtained using Cary 300 Spectrophotometer. Photo-
luminescence spectra were obtained with a Cary Eclipse fluorescence spectro-
photometer (5 nm excitation and emission band pass) and corrected for the
wavelength dependence of the detector response and monochromator trans-
mission.27 Chemiluminescence spectra were obtained by replacing the photo-
multiplier tube in the flow injection analysis manifold with an Ocean Optics
QE65Pro spectrometer with CCD detector (10 s spectra integration time, each
acquisition manually triggered in concert with reagent injection), which was
interfaced with the chemiluminescence flow-cell via fibre optic cable (1 mm core
diameter, 1.0 m length) and collimating lens (30 mm diameter, 350–2000 nm).
This enabled measurement of the chemiluminescence spectrum after each injec-
tion, as the light-producing reaction mixture passed through the flow-cell. The
presented chemiluminescence spectra are each an average of those obtained
from three injections of the reagent solution into the flow injection analysis
manifold.
Fig. 5 Loop diuretics and related compounds.
Fig. 6 Chemiluminescence responses (signal/blank ratios) of various
loop diuretics and related compounds: (1) furosemide, (2) 4-chloro-3-
sulfamoyl-benzoic acid, (3) N-benzyl-4-chloro-sulfamoylanthranillic
acid, (4) piretanide, (5) bumetanide at 1 μM, with [Ru(bpy)3]2+ (red
columns) and [Ir(df-ppy)2(pt-TEG)]
+ (blue columns), using ﬂow injection
analysis methodology. Reagent concentration: 0.1 mM. Oxidant: 1 mM
cerium(IV) sulfate in 0.05 M H2SO4. A comparison of signal/blank ratios
for the two complexes with the same y-axis scale is shown in Fig. S6 in
the ESI.†
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